Abstract
Purpose
To assess the effect of Nigella sativa (N.S) oil supplements on CVD risk factors in a crossover design for the first time.
Methods
Obese and overweight healthy women were randomized to receive N.S oil (2000 mg/day) and placebo. This intervention period lasted for 8 weeks and separated by a 4-week washout period. An iso-caloric diet was given to every individual throughout the study. Blood pressure, lipid profile, atherogenic indices and liver enzymes were measured. Pkcross procedure was performed for statistical analyses using Stata software. Cohen’s d was estimated as effect size for all outcomes to measure the magnitude of the effects.
Results
Thirty-nine participants completed the study. Capsules of N.S increased serum high-density lipoprotein cholesterol (Cohen’s d = 0.47, P = 0.009), reduced low-density lipoprotein cholesterol (Cohen’s d = − 0.33, P = 0.031), reduced TC/HDL-C ratio (as an atherogenic index, Cohen’s d = − 0.9, P < 0.001), reduced serum glutamic-oxaloacetic transaminase (Cohen’s d = 0− 0.5, P = 0.038) and reduced systolic blood pressure (Cohen’s d = − 0.4, P < 0.001). There was no effect on diastolic blood pressure measures (P = 0.96).
Conclusion
The overall improvements in cardiovascular disease (CVD) risk factors showed beneficial effects of N.S supplements among adults with obesity to prevent possible cardiovascular diseases. More studies with different designs and in other populations are suggested to clarify the exact effects of N.S as a complementary therapy for modulating CVD risk factors in individuals with overweight and obesity.
Trial registration
Iranian Registry of Clinical Trials, IRCT20180528039884N1, Registered on February 15th, 2019.
Similar content being viewed by others
Data availability
The datasets generated during the current study are available via the corresponding author on reasonable request.
Code availability
Not applicable.
Notes
Effects of oral Nigella sativa oil on the expression levels and serum concentrations of adiponectin, PPAR-γ, and TNF-α in overweight and obese women: a study protocol for a crossover-designed, double-blind, placebo-controlled randomized clinical trial (Published on August 17th, 2019).
References
Csige I, Ujvarosy D, Szabo Z, Lorincz I, Paragh G, Harangi M, Somodi S (2018) The impact of obesity on the cardiovascular system. J Diabetes Res 2018:12. https://doi.org/10.1155/2018/3407306
WHO (2018) World Health Organization: obesity, key facts. WHO. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 16 Feb 2018
Rahmani A, Sayehmiri K, Asadollahi K, Sarokhani D, Islami F, Sarokhani M (2015) Investigation of the prevalence of obesity in Iran: a systematic review and meta-analysis study. Acta Med Iran 53(10):596–607
Ghomari-Boukhatem H, Bouchouicha A, Mekki K, Chenni K, Belhadj M, Bouchenak M (2017) Blood pressure, dyslipidemia and inflammatory factors are related to body mass index in scholar adolescents. Arch Med Sci 13(1):46–52. https://doi.org/10.5114/aoms.2017.64713
Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, Okada T, Lindor K (2005) Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 41(1):64–71. https://doi.org/10.1002/hep.20543
Liu Y, Sun M, Yao H, Liu Y, Gao R (2017) Herbal medicine for the treatment of obesity: an overview of scientific evidence from 2007 to 2017. Evid Based Complement Alternat Med 2017:17. https://doi.org/10.1155/2017/8943059
Mahdavi R, Namazi N, Alizadeh M, Farajnia S (2015) Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial. Food Funct 6(6):2041–2048. https://doi.org/10.1039/c5fo00316d
Mohtashami A, Mahaki B, Azadbakht L, Entezari MH (2016) Effects of bread with Nigella sativa on lipid profiles, apolipoproteins and inflammatory factor in metabolic syndrome patients. Clin Nutr Res 5(2):89–95. https://doi.org/10.7762/cnr.2016.5.2.89
Mohtashami R, Amini M, Fallah Huseini H, Ghamarchehre M, Sadeqhi Z, Hajiagaee R, Fallah Huseini A (2011) Blood glucose lowering effects of Nigella sativa L. seeds oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. J Med Plants 3(39):90–94
Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Joukar F (2019) Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials. Integr Med Res 8(1):57–61. https://doi.org/10.1016/j.imr.2018.07.004
Hosseini MS, Mirkarimi SA, Amini M, Mohtashami R, Kianbakht S, Fallah Huseini H (2013) Effects of Nigella sativa L. seed oil in type II diabetic patients: a randomized, double-blind, placebo—controlled clinical trial. J Med Plants 12(47):93–99
Amini M, Fallah Huseini H, Mohtashami R, Sadeqhi Z, Ghamarchehre MA (2011) Hypolipidemic effects of Nigella sativa L. seeds oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. J Med Plants 10(40):133–138
Fallah Huseini H, Amini M, Mohtashami R, Ghamarchehre ME, Sadeqhi Z, Kianbakht S, Fallah Huseini A (2013) Blood pressure lowering effect of Nigella sativa L. seed oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res 27(12):1849–1853. https://doi.org/10.1002/ptr.4944
Mahdavi R, Alizadeh M, Namazi N, Farajnia S (2016) Changes of body composition and circulating adipokines in response to Nigella sativa oil with a calorie restricted diet in obese women. J Herb Med 6(2):67–72. https://doi.org/10.1016/j.hermed.2016.03.003
Razmpoosh E, Safi S, Mazaheri M, Salehi-Abargouei A, Abdollahi N, Nazari M, Fallahzadeh H, Nadjarzadeh A (2019) Effects of oral Nigella sativa oil on the expression levels and serum concentrations of adiponectin, PPAR-γ, and TNF-α in overweight and obese women: a study protocol for a crossover-designed, double-blind, placebo-controlled randomized clinical trial. Trials 20(1):512. https://doi.org/10.1186/s13063-019-3568-0
Qidwai W, Hamza HB, Qureshi R, Gilani A (2009) Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial. J Altern Complement Med 15(6):639–644. https://doi.org/10.1089/acm.2008.0367
Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, Damanhouri ZA, Anwar F (2013) A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac J Trop Biomed 3(5):337–352. https://doi.org/10.1016/S2221-1691(13)60075-1
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502
Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, Myers MG, Ogedegbe G, Schwartz JE, Townsend RR, Urbina EM, Viera AJ, White WB, Wright JT (2019) Measurement of blood pressure in humans: a scientific statement from the American heart association. Hypertension 73(5):e35–e66. https://doi.org/10.1161/HYP.0000000000000087
Gibson AA, Hsu MSH, Rangan AM, Seimon RV, Lee CMY, Das A, Finch CH, Sainsbury A (2016) Accuracy of hands v. household measures as portion size estimation aids. J Nutr Sci 5:e29–e29. https://doi.org/10.1017/jns.2016.22
Aadahl M, Jørgensen T (2003) Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc 35:1196–1202. https://doi.org/10.1249/01.MSS.0000074446.02192.14
Kim HY (2015) Statistical notes for clinical researchers: effect size. Restor Dent Endod 40(4):328–331. https://doi.org/10.5395/rde.2015.40.4.328
Ahmad M (2017) Community based, multicentered, randomized, double blinded, placebo controlled clinical trial of trachyspermum copticum extract against stable angina. Ann King Edw Med Univ 23(3):376–383
Kazemipoor M, Radzi CW, Hajifaraji M, Cordell GA (2014) Preliminary safety evaluation and biochemical efficacy of a Carum carvi extract: results from a randomized, triple-blind, and placebo-controlled clinical trial. Phytother Res 28(10):1456–1460. https://doi.org/10.1002/ptr.5147
Valizadeh N, Zakeri HR, Shafiee A, Sarkheil P, Heshmat R, Larijani B (2009) The effect of Nigella sativa extract on biochemical bone markers in osteopenic postmenopausal women. Iran J Endocrinol Metab 10(6):571–580
Al-Jawad F, Al-Attar Z (2018) Changing the lipid profile and renal functions by Allium sativum, Nigella sativa and Hibiscus sabdariffa in essential hypertensive World journal of pharmacy and pharmaceutical sciences 7. https://doi.org/10.20959/wjpps20185-11579
Khonche A, Huseini HF, Gholamian M, Mohtashami R, Nabati F, Kianbakht S (2019) Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: a randomized, double-blind and placebo-controlled clinical trial. J Ethnopharmacol 234:106–111. https://doi.org/10.1016/j.jep.2019.01.009
Sahebkar A, Beccuti G, Simental-Mendia LE, Nobili V, Bo S (2016) Nigella sativa (black seed) effects on plasma lipid concentrations in humans: a systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacol Res 106:37–50. https://doi.org/10.1016/j.phrs.2016.02.008
Kazemi T, Hajihosseini M, Moossavi M, Hemmati M, Ziaee M (2018) Cardiovascular risk factors and atherogenic indices in an Iranian population: Birjand East of Iran. Clin Med Insights Cardiol 12:1179546818759286. https://doi.org/10.1177/1179546818759286
Mainous AG, Koopman RJ, Diaz VA, Everett CJ, Wilson PWF, Tilley BC (2007) A coronary heart disease risk score based on patient-reported information. Am J Cardiol 99(9):1236–1241. https://doi.org/10.1016/j.amjcard.2006.12.035
Asgary S, Sahebkar A, Goli-Malekabadi N (2015) Ameliorative effects of Nigella sativa on dyslipidemia. J Endocrinol Invest 38(10):1039–1046. https://doi.org/10.1007/s40618-015-0337-0
Al-Naqeep G, Ismail M, Allaudin Z (2009) Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by thymoquinone-rich fraction and thymoquinone in HepG2 cells. J Nutrigenet Nutrigenomics 2(4–5):163–172. https://doi.org/10.1159/000227264
Ardakani Movaghati MR, Yousefi M, Saghebi SA, Sadeghi Vazin M, Iraji A, Mosavat SH (2019) Efficacy of black seed (Nigella sativa L.) on kidney stone dissolution: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 33:1404–1412. https://doi.org/10.1002/ptr.6331
Mahdavi R, Namazi N, Alizadeh M, Farajnia S (2016) Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: a randomized double-blind, placebo-controlled clinical trial. J Clin Lipidol 10(5):1203–1211. https://doi.org/10.1016/j.jacl.2015.11.019
Bilal A, Masud T, Uppal AM, Naveed AK (2009) Effects of Nigella sativa oil on some blood parameters in type 2 diabetes mellitus patients. Asian J Chem 21(7):5373–5381
Razmpoosh E, Safi S, Abdollahi N, Nadjarzadeh A, Nazari M, Fallahzadeh H, Mazaheri M, Salehi Abargouei A (2020) The effect of Nigella Sativa on the measures of liver and kidney parameters: a systematic review and meta-analysis of randomized-controlled trials. Pharmacol Res 156:104767. https://doi.org/10.1016/j.phrs.2020.104767
Mollazadeh H, Afshari AR, Hosseinzadeh H (2017) Review on the potential therapeutic roles of Nigella sativa in the treatment of patients with cancer: involvement of apoptosis: - black cumin and cancer. J Pharmacopuncture 20(3):158–172. https://doi.org/10.3831/kpi.2017.20.019
Prabhakar P, Reeta KH, Maulik SK, Dinda AK, Gupta YK (2015) Protective effect of thymoquinone against high-fructose diet-induced metabolic syndrome in rats. Eur J Nutr 54(7):1117–1127. https://doi.org/10.1007/s00394-014-0788-7
Awad AS, Abd Al Haleem EN, El-Bakly WM, Sherief MA (2016) Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn Schmiedebergs Arch Pharmacol 389(4):381–391. https://doi.org/10.1007/s00210-015-1207-1
Doménech M, Roman P, Lapetra J, de la Corte FJG, Sala-Vila A, de la Torre R, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Lamuela-Raventós R-M, Toledo E, Estruch R, Coca A, Ros E (2014) Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids. Hypertension 64(1):69–76. https://doi.org/10.1161/HYPERTENSIONAHA.113.03353
Leong XF, Rais Mustafa M, Jaarin K (2013) Nigella sativa and its protective role in oxidative stress and hypertension. Evid Based Complement Alternat Med 2013:120732. https://doi.org/10.1155/2013/120732
Wellek S, Blettner M (2012) On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int 109(15):276–281. https://doi.org/10.3238/arztebl.2012.0276
Rohrig B, du Prel JB, Wachtlin D, Kwiecien R, Blettner M (2010) Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int 107(31–32):552–556. https://doi.org/10.3238/arztebl.2010.0552
Ameen N, Altubaigy F, Jahangir T, Mahday IA, Mohammed EA, Musa OAA (2011) Effect of Nigella sativa and bee honey on pulmonary, hepatic and renal function in Sudanese in Khartoum state. J Med Plants Res 5(31):6857–6863. https://doi.org/10.5897/jmpr11.1357
Amin G, Mousavi A, Vosough S, Azar ZJ, Shariat M, Haghollahi F, Afshar S (2018) Therapeutic effect of combination of Nigella sativa, Melissa officinalis extract and fennel fruit with citalopram on menopausal symptoms. Tehran Univ Med J 76(6):417–425
Acknowledgements
We would like to express our gratitude to all the participants and members who participated in this study as well as the obesity clinic at Shahid Sadoughi University of Medical Sciences, and Barij Essence Pharmaceutical Co. for their executive supports. We would also like to thank Shahid Sadoughi University of Medical Sciences and Iran’s National Science Foundation (INSF) for their financial and executive supports.
Funding
This study is funded by Shahid Sadoughi University of Medical Sciences (No. 961020). Moreover, Iran’s National Science Foundation (INSF) has provided an educational grant funding for this trial (No. 96012986).
Author information
Authors and Affiliations
Contributions
All authors contributed to the idea and design of the study. ER and SF performed the idea of this study, study design, and were major contributors to the writing and reviewing of the manuscript. AN and MM reviewed and contributed to the manuscript. ER, SF, NA and MN participated in the design, participant recruitment and performing laboratory tests. HF and ASA provided statistical expertise in clinical trial design and reviewed and contributed to the manuscript. ASA and ER edited the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interest
The authors declare that they have no conflict of interest.
Ethical approval
The protocol of the present study was approved by the ethics committee of Shahid Sadoughi University of Medical Sciences on December 15th, 2018 (IR.SSU.SPH.REC.1397.007). A previously published protocol article with detailed design, ethics approval and details of participation is also available for this study Footnote 1.
Consent to participate
All the participants were asked to sign an informed consent form after providing them related information about the procedure of the study. Participant recruitment was started on April 21st, 2019.
Consent for publication
Not applicable.
Rights and permissions
About this article
Cite this article
Razmpoosh, E., Safi, S., Nadjarzadeh, A. et al. The effect of Nigella sativa supplementation on cardiovascular risk factors in obese and overweight women: a crossover, double-blind, placebo-controlled randomized clinical trial. Eur J Nutr 60, 1863–1874 (2021). https://doi.org/10.1007/s00394-020-02374-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-020-02374-2